A Prospective Multicenter Open-Label Study of the Effectiveness of Epoetin Beta for Patients with Low/Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Preliminary Result

被引：3

作者：

Chuncharunee, Suporn ^{[1
]}

Kanitsap, Nonglak ^{[2
]}

Suwanban, Tawatchai ^{[3
]}

Khuhapinant, Archrob ^{[4
]}

Uaprasert, Noppacharn ^{[5
]}

Chansung, Kanchana ^{[6
]}

Rattarittamrong, Ekarat ^{[7
]}

Wongkhantee, Somchai ^{[8
]}

Siritanaratanakul, Noppadol ^{[4
]}

Norasetthada, Lalita ^{[7
]}

Nakorn, Thanyaphong Na ^{[5
]}

Charnwiboonsri, Chadchai ^{[9
]}

机构：

[1] Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, Thailand

[2] Thammasat Univ, Dept Internal Med, Pathum Thani, Thailand

[3] Rajavithi Hosp, Dept Internal Med, Bangkok, Thailand

[4] Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok, Thailand

[5] Chulalongkorn Univ, Dept Med, Bangkok, Thailand

[6] Khon Kaen Univ, Dept Internal Med, Khon Kaen, Thailand

[7] Chiang Mai Univ, Dept Internal Med, Chiang Mai, Thailand

[8] Khonkaen Reg Hosp, Dept Internal Med, Khon Kaen, Thailand

[9] Roche Thailand Ltd, Med Dept, Bangkok, Thailand

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.5543.5543

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5543

引用

页数：4

共 50 条

[31] Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes [J].

Al-Kali, Aref ;

Saliba, Antoine ;

Yi, Cecilia Y. Arana ;

Foran, James M. ;

Tanoue, Yasushi ;

Yamamoto, Maki ;

Gullbo, Joachim ;

Garcia-Manero, Guillermo .

BLOOD, 2023, 142

[32] The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study [J].

Liang, Ying ;

Cao, Changan ;

Zhu, Cheng ;

Wang, Chuanyue ;

Zhang, Congpei ;

Dong, Fang ;

Yang, Fude ;

Deng, Hong ;

Yu, Jingjie ;

Tang, Jisheng ;

Su, Lei ;

Xin, Limin ;

Hong, Ling ;

Gao, Minglong ;

Tang, Muni ;

Xie, Shiping ;

Lu, Shuiping ;

Liu, Tiebang ;

Xu, Xiaojin ;

Wang, Xijin ;

Li, Xuanzi ;

Wang, Xueyi ;

Li, Yi ;

Zhang, Yong ;

Chen, Zhiyu ;

Yu, Xin .

ASIA-PACIFIC PSYCHIATRY, 2016, 8 (03) :241-244

[33] Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain [J].

Yoon, Do Heum ;

Bin, Seong-Il ;

Chan, Simon Kin-Cheong ;

Chung, Chun Kee ;

In, Yong ;

Kim, Hyoungmin ;

Lichauco, Juan Javier ;

Mok, Chi Chiu ;

Moon, Young-Wan ;

Ng, Tony Kwun-Tung ;

Penserga, Ester Gonzales ;

Shin, Dong Ah ;

You, Dora ;

Moon, Hanlim .

BMC MUSCULOSKELETAL DISORDERS, 2017, 18

[34] Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain [J].

Do Heum Yoon ;

Seong-Il Bin ;

Simon Kin-Cheong Chan ;

Chun Kee Chung ;

Yong In ;

Hyoungmin Kim ;

Juan Javier Lichauco ;

Chi Chiu Mok ;

Young-Wan Moon ;

Tony Kwun-Tung Ng ;

Ester Gonzales Penserga ;

Dong Ah Shin ;

Dora You ;

Hanlim Moon .

BMC Musculoskeletal Disorders, 18

[35] ARCADE (20090160): A randomized controlled trial of darbepoetin alpha in anemic patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) [J].

Gasal, E. ;

Pan, C. ;

Tankersley, C. .

LEUKEMIA RESEARCH, 2013, 37 :S166-S167

[36] Outcome of Patients (pts) with Low and Intermediate-1 Risk Myelodysplastic Syndrome (MDS) After Hypomethylating Agent (HMA) Failure. [J].

Jabbour, Elias J. ;

Daver, Naval G. ;

Dong, Tina ;

Kadia, Tapan M. ;

O'Brien, Susan ;

Cortes, Jorge E. ;

Ravandi, Farhad ;

Pemmaraju, Naveen ;

Ghanem, Hady ;

Faderl, Stefan ;

Borthakur, Gautam ;

Kantarjian, Hagop M. ;

Garcia-Manero, Guillermo .

BLOOD, 2012, 120 (21)

[37] LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY [J].

Platzbecker, U. ;

Germing, U. ;

Giagounidis, A. ;

Goetze, K. ;

Kiewe, P. ;

Mayer, K. ;

Ottmann, O. ;

Radsak, M. ;

Wolff, T. ;

Haase, D. ;

Hankin, M. ;

Wilson, D. ;

Zhang, X. ;

Laadem, A. ;

Sherman, M. ;

Attie, K. .

HAEMATOLOGICA, 2015, 100 :192-192

[38] Karyotype evolution in patients with MDS and isolated deletion (5q) with IPSS low or intermediate-1-risk: Results of LeMon5 study [J].

Shirneshan, K. ;

Platzbecker, U. ;

Nolte, F. ;

Giagounidis, A. ;

Goetze, K. ;

Braulke, F. ;

Schanz, J. ;

Germing, U. ;

Haase, D. .

ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 :233-234

[39] ACE-536 INCREASES HEMOGLOBIN LEVELS IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY [J].

Platzbecker, U. ;

Germing, U. ;

Giagounidis, A. ;

Goetze, K. ;

Kiewe, P. ;

Mayer, K. ;

Ottmann, O. ;

Radsak, M. ;

Wolff, T. ;

Hankin, M. ;

Wilson, D. ;

Sherman, M. ;

Attie, K. .

HAEMATOLOGICA, 2014, 99 :500-500

[40] LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY [J].

Platzbecker, U. ;

Germing, U. ;

Giagounidis, A. ;

Goetze, K. ;

Kiewe, P. ;

Mayer, K. ;

Ottmann, O. ;

Radsak, M. ;

Wolff, T. ;

Haase, D. ;

Hankin, M. ;

Wilson, D. ;

Zhang, X. ;

Laadem, A. ;

Sherman, M. ;

Attie, K. .

LEUKEMIA RESEARCH, 2015, 39 :S25-S25

← 1 2 3 4 5 →